National and Kapodistrian University of Athens
Ο ρόλος της κυτταροκίνης TL1A στην επαγωγή της φλεγμονής σε χρόνια νοσήματα
Abstract
dc:descriptionIntroduction: TNF-like cytokine 1A (TL1A) and its decoy receptor DcR3 are members of the TNF superfamily and the TNF receptor superfamily of proteins, respectively. Their role as a ligand/receptor pair in the pathogenesis of chronic intestinal inflammation in inflammatory bowel disease (IBD) has not been fully elucidated. Aim: To study the mucosal and systemic expression of DcR3 and TL1A in ulcerative colitis (UC) and Crohn’s disease (CD), in relation to disease activity, localization, and response to treatment.Methods: Soluble DcR3 and TL1A were measured by ELISA in IBD patients and healthy controls (HC). Relative mRNA expression in non-affected and inflamed intestinal mucosa was determined by real-time RT-PCR. Results: We observed a significant upregulation of soluble DcR3 in patients with active UC (median, 95% CI: 470.4, 0–5500 pg/ml) when compared to UC in remission (0, 0–2761.4 pg/ml, P=0.003) and HC (0, 0–726 pg/ml, P<0.0001). Correspondingly, soluble DcR3 was significantly elevated in active CD (0, 0-1576.4 pg/ml) in comparison to CD in remission (0, 0–689.0 pg/ml, P=0.023) and HC (0, 0-642.6 pg/ml, P=0.021). Circulating levels of ΤL1A were significantly higher in active UC (median, 95% CI: 432.4, 174–7691.5 pg/ml), and UC in remission (389.3, 0–6654.8 pg/ml) when compared to HC (187.4, 0–2166.5, P<0.0001 for both comparisons). Soluble TL1A levels were found to be higher in active CD (428.2, 0 – 2009.6 pg/ml) than in HC (197.0, 0 – 1570.3 pg/ml, P=0.007) but not compared to CD in remission (224.0, 0 – 1570.3 pg/ml, P=NS).Effective treatment resulted in disappearance or significant decrease of systemic DcR3 levels both in UC (median, 95% CI, pre-treatment: 0, 0–1840.9 pg/ml vs post-treatment: 822.5, 333.8–4951.1, P=0.006) and CD (median, 95% CI, pre-treatment: 407.2, 282.1 – 735.4 pg/ml, post-treatment: 0, 0 – 282.4, P=0.008). DcR3 and TL1A mRNA transcripts were found to be significantly elevated in inflamed areas of the colon in UC when compared with non-inflamed areas from the same UC patients and normal mucosa from HC (mean SD, DcR3, HC mucosa: 5.6 ± 1.4 vs. non-inflamed UC: 12.5 ± 10.4 vs. inflamed UC: 144.3 ± 97.6, P<0.0001 and for TL1A, HC mucosa: 16.2 ± 3.8, non-inflamed: 16.2 ± 10.9 vs. inflamed: 71.0 ± 65.4, P=0.001). Mucosal expression of DcR3 is upregulated in colonic areas with active inflammation in CD patients in comparison to non-inflamed areas from patients and normal mucosa from HC (HC mucosa: 5.4 ± 1.2 vs. non-inflamed: 8.6 ± 4.0 vs. inflamed: 28.9 ± 21.7, P<0.001). A clear upregulation of DcR3 mRNA in inflamed CD ileum which was highly significant when compared to HC was also observed (HC: 13.5 ± 11.7 vs. inflamed CD ileum: 101.3 ± 69.2, P=0.006). On the other hand, relative ΤL1A mRNA expression in the inflamed CD colon (45.4 ± 24.8) is significantly elevated in comparison to HC mucosa (16.4 ± 3.6, P=0.019) but not when compared to non-inflamed areas from CD patients (25.7 ± 20.1, P=NS). Moreover, ΤL1A expression in the inflamed terminal ileum of CD patients shows no difference in comparison to ileal samples from HC (HC: 74.6 ± 33.3 vs. inflamed CD ileum: 139.2 ± 155.4, P= NS). Furthermore, soluble ΤL1A levels were higher in patients with inflammation of the colon (median, 95% CI: 603.4, 0–1612 pg/ml) in comparison to those with isolated small intestinal disease (222.3, 0 – 2010 pg/m, P=0.042).Conclusions: In patients with active UC and CD there is a clear upregulation of circulating TL1A and DcR3 levels and relative expression of DcR3 mRNA is upregulated in areas with active inflammation. ΤL1A mRNA expression is upregulated in inflamed UC mucosa, while in CD the upregulation of mucosal and systemic TL1A is preferentially associated with colonic inflammation. Serum DcR3 is decreased in IBD in response to effective treatment. TL1A/DR3/DcR3-mediated pathways may participate in the pathogenesis of IBD.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Siakavellas, Spyridon
- Σιακαβέλλας, Σπυρίδων
Subjects
dc:subject × 15Rights
dc:rights- Statement dc:rights
-
- BY_NC_ND
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/36769